BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25721249)

  • 1. Suppressive Effect of Matrine on Tumor Invasion in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Urinary Bladder Carcinogenesis.
    Gao H; Guo Y; Deng N; Fei P; Qiu X; Zheng P; Feng J; Dai G
    Chemotherapy; 2014; 60(2):119-128. PubMed ID: 25721249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B; Balakrishnan D; Sundaresan S
    Hum Exp Toxicol; 2016 Jun; 35(6):685-92. PubMed ID: 26251508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
    J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
    Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
    J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
    Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1-hexylcarbamoyl-5-fluorouracil on development of rat urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ozono S; Iwata H; Tsunemi K; Takahashi S; Matsuki H; Sasaki K; Hirao Y; Okajima E
    Jpn J Exp Med; 1988 Jun; 58(3):123-7. PubMed ID: 3184501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
    Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
    Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Fukushima S; Shibata M; Shirai T; Ogiso T; Ito N
    Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
    Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and carcinogenesis: morphologic observations in the rat bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Zhang X; Takenaka I
    Int J Urol; 1998 May; 5(3):262-7. PubMed ID: 9624559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
    Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
    Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
    Szende B; Jeney A; Institoris L
    Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of liarozole on the cell proliferation activity in the rat urinary bladder epithelium induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Nagae H; Otawara Y; Suzuki K; Fujita K
    Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):838-42. PubMed ID: 10565163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
    Samma S; Tabata S; Nakatsuji F; Yoshie T; Moriya A; Matsuki H; Watanabe S; Babaya K; Hirao Y; Okajima E
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1661-8. PubMed ID: 3927848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
    Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
    Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Okajima E; Hiramatsu T; Okamoto M; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Kubota K; Samma S; Okamura K; Kaneko Y; Horii Y; Moriya A
    Gan To Kagaku Ryoho; 1982 May; 9(5):836-42. PubMed ID: 7184430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
    Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
    Fukushima S; Murasaki G; Hirose M; Nakanishi K; Hasegawa R; Ito N
    Acta Pathol Jpn; 1982 Mar; 32(2):243-50. PubMed ID: 7090816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.